Apraclonidine and LASIK.
Aslanides
Ioannis M
IM
Tsiklis
Nikolaos S
NS
Pallikaris
Ioannis G
IG
Jankov
Mirko R
MR
Coskunseven
Efekan
E
Ozkilic
Efekan
E
D000287:Administration, Topical; D000293:Adolescent; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage*; D000328:Adult; D003000:Clonidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003229:Conjunctival Diseases / Q000517:prevention & control*; D004311:Double-Blind Method; D005130:Eye Hemorrhage / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006940:Hyperemia / Q000517:prevention & control*; D020731:Keratomileusis, Laser In Situ; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000601:surgery; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D011183:Postoperative Complications / Q000517:prevention & control*; D011446:Prospective Studies; D013524:Surgical Flaps; D013529:Surgical Wound Dehiscence / Q000517:prevention & control
D000316:Adrenergic alpha-Agonists; D009883:Ophthalmic Solutions; C016986:apraclonidine; D003000:Clonidine